Cyclacel pharmaceuticals to release third quarter 2022 financial results

Berkeley heights, n.j., nov. 03, 2022 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce third quarter 2022 financial results on wednesday, november 9, 2022. the company will host a conference call and live webcast at 4:30 p.m. eastern time on the same day.
CYCC Ratings Summary
CYCC Quant Ranking